References
- Bachur N. R., Gordon S. L., Gee M. V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Research 1978; 38: 1745–1750
- Bass H., Moore J. L., Coakley W. T. Lethality in mammalian cells due to hyperthermia under oxic and hypoxic conditions. International Journal of Radiation Biology 1978; 33: 57–67
- Braun J., Hahn G. M. Enhanced cell killing by bleomycin and 43°C hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Research 1975; 35: 2921–2927
- Claycamp H. G., Shaw E. I., Zimbrick J. D. Spin-label substitutions in cisplatin reduce toxicity and interaction with radiation. Radiation Research 1986; 106: 141–146
- Dolbeare F., Beiski W., Pallavicini M. G., Vanderlaan M., Gray J. W. Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity. Cytometry 1985; 6: 521–530
- Gerweck L. E., Nygaard T. G., Burlett M. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Research 1979; 39: 966–972
- Hahn G. M., Strande D. P. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. Journal of the National Cancer Institute 1976; 57: 1063–1067
- Herman T. S. Temperature dependent of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro. Cancer Research 1983; 43: 517–520
- Herman T. S., Teicher B. A., Collins L. S. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures. Cancer Research 1988; 48: 2342–2347
- Kennedy K. A., Rockwell S., Sartorelli A. C. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Research 1980; 40: 2356–2360
- Kim S. H., Kim J. H., Hahn E. W. The radiosensitization of hypoxic tumor cells by hyperthermia. Radiology 1975; 114: 727–728
- Leith J. T., Miller R. C., Gerner E. W., Boone M. L. M. Hyperthermic potentiation: biological aspects and applications to radiation therapy. Cancer 1977; 39: 766–779
- Lin A., Cosby L. A., Sartorelli A. C. Potential bioreductive alkylating agents. Cancer Chemotherapy, A. C. Sartorelli, A. C. Sartorelli. American Chemical Society, Washington, DC 1976; 71–86
- Melvik J. E., Pettersen E. O. Oxygen-and Temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro. Radiation Research 1988; 114: 489–499
- Monge O. R., Rofstad E. K., Kaalhus O. Thermochemotherapy in vitro of a C3H mouse mammary carcinoma: single fraction heat and drug treatment. European Journal of Cancer and Clinical Oncology 1988; 24: 1661–1669
- Palzer R. J., Heidelberger C. Influence of drugs and synchrony on the hyperthermic killing of HeLa cells. Cancer Research 1973; 33: 422–427
- Rose W. C., Veras G. H., Laster W. R., Jr, Schabel F. M., Jr. Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors. Cancer Treatment Reports 1979; 63: 1311–1325
- Sausville E. A., Stein R. W., Peisach J., Horwiz S. B. Properties and products of the degradation of DNA by bleomycin and iron(II). Biochemistry 1978; 17: 2746–2754
- Teicher B. A., Lazo J. S., Sartorelli A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Research 1981a; 41: 73–81
- Teicher B. A., Kowal C. D., Kennedy K. A., Sartorelli A. C. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Research 1981b; 41: 1096–1099
- Yamauchi T., Raffin T. A., Yang P., Sikic B. I. Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin. Cancer Chemotherapy and Pharmacology 1987; 19: 282–286
- Yamazaki K. Tumorigenicity of established human glioma cell lines in lasat and nude mice. Neuropathology 1982; 3: 29–38, (in Japanese)